The people behind Helix

We’re a rapidly growing company working out of the Bay Area and San Diego.

Scientific Advisory Board

Our advisory board is comprised of the world’s foremost experts in genomics. Each member serves an important role in upholding our high scientific standards and serves as a strategic resource as we build an ongoing destination for DNA discovery.

Robin Thurston

Robin Thurston

Chief Executive Officer

James Lu, MD, PhD

James Lu, MD, PhD

Co-founder & SVP, Applied Genomics

Justin Kao

Justin Kao

Co-founder & SVP, Business Development & Partnerships

Scott Burke

Co-founder & Chief Technology Officer

Deena Bahri

Deena Bahri

Chief Marketing Officer

Chris Glode

Chris Glode

Chief Product Officer

Ajay Gopal

Ajay Gopal

Chief Financial Officer

Dawn Barsy

Dawn Barsy

VP, Legal

Philippe Lyko

Philippe Lyko

VP, Finance

Jade Curtis

Jade Curtis

VP, People Operations

Jim Chou

Jim Chou

VP, Engineering

Will Lee, PhD

Will Lee, PhD

VP, Bioinformatics

David Becker

David Becker, PhD

VP, Laboratory Operations

Marc Laurent

Marc Laurent

VP, Operations

Jessica Graham

Jessica Graham

VP, Brand Marketing

Roberto Veronese

Roberto Veronese

VP, Product Design

Jorge Tapias

Jorge Tapias

VP, Partnerships

Ofer Mendelevitch

Ofer Mendelevitch

VP, Data Science in Engineering

Robert Green, MD, MPH

Robert Green, MD, MPH

Robert Green, MD, MPH is Chairman of the Helix Scientific Advisory Board. He is also Professor of Medicine and Director of the Genomes2People Research Program at Brigham and Women’s Hospital and Harvard Medical School, and an associate member of the Broad Institute. Dr. Green’s research focuses upon randomized trials and observational studies to assess the medical, behavioral and economic outcomes of using genomics in medicine and society.

Nita Farahany, JD, PhD

Nita Farahany, JD, PhD

Nita Farahany, JD, PhD is Professor of Law and Philosophy, Director of Duke Science & Society at Duke University, and a member of the Presidential Commission for the Study of Bioethics. Her research focuses on how developments in behavioral genetics and neuroscience inform societal norms about privacy and individual liberty.

Goncalo Abecasis, PhD

Goncalo Abecasis, PhD

Goncalo Abecasis, PhD, is Felix E. Moore Collegiate Professor of Biostatistics and Chair of the Department of Biostatistics at the University of Michigan. Dr. Abecasis’ research focuses on the development of statistical tools for the identification and study of genetic variants important in human disease.

Judy Garber, MD, MPH

Judy Garber, MD, MPH

Judy Garber, MD, MPH is Professor of Medicine at Harvard Medical School and Director, Center for Cancer Genetics and Prevention at Dana Farber Cancer Institute. Dr. Garber’s recent research has evaluated novel agents targeting DNA repair defects in treatment and prevention of triple-negative or basal-like breast cancer.

Atul Butte, MD, PhD

Atul Butte, MD, PhD

Atul Butte, MD, PhD is Professor of Pediatrics and Director of the Institute of Computational Health Sciences (ICHS) at the University of California, San Francisco. Dr. Butte’s laboratory builds and applies tools that integrate molecular, clinical, and epidemiological data into diagnostics, therapeutics, and new insights into disease.

Keith Stewart, MB, CHB

Keith Stewart, MB, CHB

Keith Stewart, MB, CHB is the Carlson and Nelson Endowed Director, Mayo Clinic Center for Individualized Medicine and the Vasek and Anna Maria Polak Professor of Cancer Research. Dr. Stewart is responsible for systematically introducing clinical genomics to routine medical practice at Mayo Clinic incorporating prevention, diagnosis and treatment across the spectrum of medical specialties.